Regulated secretion in Tetrahymena thermophila: A unique recombinant protein production platform and vaccine formulation strategy
Paul Colussi¹, Ashot Papoyan¹, Heather O'Neil¹, Xujie Zhang¹, Yelena Bisharyan¹, Donna Cassidy Hanley² and Ted Clark², (1)Tetragenetics Inc, Ithaca, NY, (2)Department of Microbiology and Immunology, Cornell Univeristy

Production of virus-like particles (VLPs) in a fungal production platform
Debbie Higgins, Edward B. Cambareri, Silke Allgaier, Yuliya Brudnaya and W. Dorsey Stuart, Neugenesis Corporation, Burlingame, CA

Break

Fermentation excellence enabled via innovative technologies
Meg Gao¹, Patrick Farrell¹, Tony D'Amore¹ and Xuefeng Yu², (1)Bioprocess Research and Development, Sanofi Pasteur, Toronto, ON, Canada, (2)CanSino Biotechnology Inc, TianJin, China

Non-replicating adenovirus-vectored avian influenza vaccine as a tool for mitigating a pandemic
De-chu C. Tang¹, Scott D. Parker², Haroldo Toro³, Jianfeng Zhang¹, Zhongkai Shi¹, Tsungwei Feng¹, Diana L. Noah⁴, Nutan Mytle⁴ and Kent R. Van Kampen¹, (1)Vaxin Inc., Birmingham, AL, (2)University of Alabama at Birmingham, Birmingham, AL, (3)Auburn University, Auburn, AL, (4)Southern Research Institute, Birmingham, AL

H5 Pandemic Influenza Vaccine: Scale-up of transient plant-based expression system
Brigitte Barbeau, Manufacturing, Medicago, Quebec, QC, Canada